- Downloading an IMBRUVICA™ Order Form at www.Onco360.com and faxing it to 877-662-6355;
- Calling 877-662-6633; or
- e-Prescribing to OncoMed, The Oncology Pharmacy.
Onco360, the nation’s fastest-growing independent Oncology Pharmacy and Clinical Support Services company, is proud to be part of the limited Specialty Pharmacy Network of IMBRUVICA™ (ibrutinib). IMBRUVICA™ is now also indicated for the treatment of patients with Chronic Lymphocytic Leukemia (CLL) who have received at least one prior therapy. This indication is based on overall response rate. An improvement in survival or disease-related symptoms has not been established. Dosing for CLL The recommended dose of IMBRUVICA™ for CLL is 420 mg (three 140 mg capsules) orally once daily. IMBRUVICA™ is commercially available immediately through Onco360 and its network of OncoMed Pharmacies. Orders can be placed by: